Access Advocate for Clinical Research Participation

Access Advocate for Clinical Research Participation sits under the Michael J. Fox Foundation for Parkinson's Research and funds implementation of an Access Advocate model at clinical trial sites. The aim is to improve inclusive enrollment and retention in Parkinson's trials through practical, relationship-based site workflows rather than broad community outreach alone. The award is fixed at $200,000 for 24 months. Eligible sites are in the United States or Canada and must have active or planned interventional Parkinson's trials. The current deadline is June 16, 2026, at 5 p.m. US ET, and applicants need to show strong study volume, defined advocate roles with training, trackable workflows, and a willingness to share what they learn across sites. This program fits research centers that already run meaningful Parkinson's trial activity and want to improve who gets enrolled and who stays enrolled. It is less about general awareness work and more about building a repeatable site process with clear accountability. Teams that can operationalize the model and show that the approach will travel beyond a single site will be strongest.

Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.